Nkarta Announces November & December 2020 Investor Conference Schedule

Rhea-AI Summary

Nkarta, a clinical-stage biopharmaceutical company focused on developing engineered natural killer (NK) cell therapies for cancer, has announced its participation in several upcoming investor conferences.

The events include:

• Cowen 2020 IO Next Summit on November 13, 2020, at 11:45 a.m. ET
• Stifel 2020 Virtual Healthcare Conference on November 17, 2020, at 2:00 p.m. ET
• Evercore ISI 3rd Annual HealthCONx Conference on December 1, 2020, at 9:40 a.m. ET

Audio webcasts will be available on Nkarta's website, with replays archived for about four weeks.

Positive

• Participation in multiple investor conferences may enhance visibility and attract potential investors.

Negative

• None.

SOUTH SAN FRANCISCO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at these upcoming investor conferences:

Cowen 2020 IO Next Summit
Date: Friday, November 13, 2020
Fireside chat presentation: 11:45 a.m. ET

Stifel 2020 Virtual Healthcare Conference
Date: Tuesday, November 17, 2020
Fireside chat presentation: 2:00 p.m. ET

Evercore ISI 3^rd Annual HealthCONx Conference
Date: Tuesday, December 1, 2020
Fireside chat presentation: 9:40 a.m. ET

A live audio webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com. A replay of the webcast will be archived on the website for approximately four weeks.

About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body. For more information, please visit the company’s website at www.nkartatx.com.

Nkarta Media/Investor Contact:
Greg Mann
Nkarta, Inc.
gmann@nkartatx.com

FAQ

What is Nkarta's upcoming conference schedule?

Nkarta will participate in the Cowen 2020 IO Next Summit on November 13, the Stifel 2020 Virtual Healthcare Conference on November 17, and the Evercore ISI 3rd Annual HealthCONx Conference on December 1.

When will Nkarta's presentations occur?

The Cowen presentation is at 11:45 a.m. ET on November 13, Stifel at 2:00 p.m. ET on November 17, and Evercore at 9:40 a.m. ET on December 1.

How can I access Nkarta's conference webcasts?

Live audio webcasts for Nkarta's events will be available on their website, with replays accessible for approximately four weeks.

What is Nkarta's focus in biopharmaceuticals?

Nkarta focuses on developing engineered natural killer (NK) cell therapies aimed at treating cancer.